Andera Partners

Latest statistics and disclosures from Andera Partners's latest quarterly 13F-HR filing:

  • Top 5 stock holdings are KMTS, MLYS, AVLN, AGMB, IVA, and represent 99.13% of Andera Partners's stock portfolio.
  • Reduced shares in these 2 stocks: EVMN (-$11M), ABVX (-$10M).
  • Sold out of its position in ABVX.
  • Andera Partners was a net seller of stock by $-21M.
  • Andera Partners has $176M in assets under management (AUM), dropping by -14.91%.
  • Central Index Key (CIK): 0001757283

Tip: Access up to 7 years of quarterly data

Positions held by Andera Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Portfolio Holdings for Andera Partners

Andera Partners holds 7 positions in its portfolio as reported in the September 2026 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Kestra Med Technologies SHS (KMTS) 43.9 $77M 2.7M 28.29
 View chart
Mineralys Therapeutics (MLYS) 22.8 $40M 1.6M 25.13
 View chart
Avalyn Pharmaceuticals Com Shs (AVLN) 15.1 $27M 930k 28.49
 View chart
Agomab Therapeutics Nv Sponsored Ads (AGMB) 9.7 $17M 1.5M 11.10
 View chart
Inventiva Sa Ads (IVA) 7.6 $13M 3.6M 3.69
 View chart
Evommune Com Shs (EVMN) 0.5 $804k -93% 97k 8.26
 View chart
Nyxoah S A SHS (NYXH) 0.4 $720k 522k 1.38
 View chart

Past Filings by Andera Partners

SEC 13F filings are viewable for Andera Partners going back to 2026